Dynamic Contrast-Enhanced Magnetic Resonance Imaging as a Surrogate Biomarker for Bevacizumab in Colorectal Cancer Liver Metastasis: A Single-Arm, Exploratory Trial

PURPOSE: The purpose of this study is to investigate dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and plasma cytokines and angiogenic factors (CAFs) as pharmacodynamic and prognostic biomarkers of bevacizumab monotherapy in colorectal cancer with liver metastasis (CRCLM). MATERIALS...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Yeo-Eun, Joo, Bio, Park, Mi-Suk, Shin, Sang Joon, Ahn, Joong Bae, Kim, Myeong-Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5080817/
https://www.ncbi.nlm.nih.gov/pubmed/26987390
http://dx.doi.org/10.4143/crt.2015.374

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5080817/
https://www.ncbi.nlm.nih.gov/pubmed/26987390
http://dx.doi.org/10.4143/crt.2015.374

Ejemplares similares